TrialDrug design, development and therapy2026

Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects.

Guiling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.